Cigna Group (NYSE:CI) Given Overweight Rating at Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of Cigna Group (NYSE:CI) in a report issued on Friday,Benzinga reports. The brokerage currently has a $340.00 price target on the health services provider’s stock.

Several other brokerages also recently issued reports on CI. Royal Bank Of Canada reiterated an “outperform” rating and set a $337.00 price target on shares of Cigna Group in a report on Thursday, October 1st. Piper Sandler reiterated an “overweight” rating on shares of Cigna Group in a report on Friday, October 23rd. Robert W. Baird set a $362.00 target price on shares of Cigna Group in a research report on Friday, July 31st. Guggenheim boosted their target price on shares of Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a report on Friday, July 31st. Finally, Raymond James Financial cut shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and decreased their price target for the company from $350.00 to $320.00 in a research report on Monday, August 3rd. Fourteen analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $335.70.

Cigna Group Price Performance

NYSE:CI traded down $7.82 during mid-day trading on Friday, reaching $293.66. The stock had a trading volume of 2,427,984 shares, compared to its average volume of 1,441,425. The stock has a 50-day simple moving average of $285.81 and a two-hundred day simple moving average of $282.17. The stock has a market capitalization of $77.60 billion, a PE ratio of 12.96, a P/E/G ratio of 1.00 and a beta of 0.25. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a 12 month low of $255.53 and a 12 month high of $318.05.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, November 5th. The health services provider reported $7.98 earnings per share for the quarter, topping the consensus estimate of $7.52 by $0.46. The firm had revenue of $73.79 billion during the quarter, compared to analysts’ expectations of $72.64 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%. The company’s quarterly revenue was up 5.6% on a year-over-year basis. During the same period in the prior year, the company earned $7.83 earnings per share. On average, equities analysts anticipate that Cigna Group will post 30.52 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be issued a $1.56 dividend. The ex-dividend date is Thursday, December 3rd. This represents a $6.24 annualized dividend and a yield of 2.1%. Cigna Group’s dividend payout ratio is presently 25.82%.

Insider Buying and Selling

In other news, insider Nicole Jones sold 2,677 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the transaction, the insider owned 25,880 shares in the company, valued at approximately $7,236,306.80. The trade was a 9.37% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the company’s stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the sale, the insider directly owned 5,053 shares in the company, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.

Institutional Trading of Cigna Group

A number of institutional investors have recently bought and sold shares of CI. BlackRock Inc. raised its position in shares of Cigna Group by 3.7% in the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock worth $6,461,457,000 after acquiring an additional 840,098 shares in the last quarter. GQG Partners LLC bought a new stake in shares of Cigna Group during the 2nd quarter valued at about $1,628,918,000. Bank of America Corp DE grew its stake in Cigna Group by 8.8% during the first quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock worth $848,821,000 after purchasing an additional 256,677 shares during the period. Dimensional Fund Advisors LP grew its stake in Cigna Group by 10.8% during the first quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider’s stock worth $647,008,000 after purchasing an additional 236,340 shares during the period. Finally, Legal & General Group Plc acquired a new stake in Cigna Group during the second quarter worth approximately $542,779,000. Institutional investors own 86.99% of the company’s stock.

Cigna Group News Roundup

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Third-quarter adjusted earnings were $7.98 per share, ahead of estimates, while revenue rose 6% to about $73.8 billion and also exceeded consensus. Strength in Cigna Healthcare and a favorable pharmacy benefit mix supported results. Cigna Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share. Employer medical growth is expected to help offset Cigna’s exit from the ACA individual market. Cigna lifts 2026 outlook
• Positive Sentiment: At its investor event, Cigna outlined a multi-year $3 billion modernization and productivity program, targeting 10%–14% adjusted EPS growth annually and approximately $50 billion in cumulative operating cash flow through 2030. Cigna raises 2026 outlook after strong quarter
• Neutral Sentiment: Analyst views remain supportive: Cantor Fitzgerald reaffirmed Overweight with a $340 target. Guggenheim kept a Buy rating but lowered its target to $347 from $361, tempering the positive signal. Guggenheim ratings
• Negative Sentiment: Despite higher adjusted earnings, reported GAAP net income fell to $1.4 billion from $1.87 billion a year earlier. The ACA individual-market exit also brings transition and execution risks, even as employer business growth is expected to offset it. Cigna Group lifts outlook as revenue climbs

About Cigna Group

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members.

Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

The company serves customers in the United States and select international markets.